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Research
Swimming in pools is an important recrea-
tional activity for hundreds of millions of peo-
ple worldwide and has been associated with 
significant positive health benefits (Zwiener 
et al. 2007). Hygiene and water quality, espe-
cially infections caused by feces-associated 
microbes and protozoa, have been a priority 
for regulators and researchers (World Health 
Organization 2006). However, concerns have 
been raised regarding potential adverse health 
effects resulting from exposure to chemically 
disinfected swimming pool water (Zwiener 
et al. 2007).
As with drinking water, chlorination is 
the most common method of disinfection 
for swimming pools. The addition of chlo-
rine to water results in the formation of hun-
dreds of chlorination by-products because of 
the presence of organic matter (Richardson 
et al. 2007). Levels of disinfection by-prod-
ucts (DBPs) in swimming pool water are 
not necessarily higher than those in drinking 
water (Richardson et al. 2010). Swimming 
in an indoor pool, however, leads to a high 
uptake of compounds such as trihalo methanes 
(THMs), which are inhaled and absorbed by 
the skin (Whitaker et al. 2003; Xu and Weisel 
2004, 2005). High levels of halo acetic acids 
also have been reported in swimming pools; 
however, these DBPs are likely not taken up at 
significant levels because they are non volatile, 
and uptake occurs mainly through ingestion. 
Another chemical class identified recently in 
chlorinated pools is nitrosamines (Walse and 
Mitch 2008), but their uptake via swimming 
has not been studied.
Epidemiological studies have shown that 
long-term consumption of chlorinated water 
and exposure to THMs at levels found cur-
rently in drinking water in many industrialized 
countries are associated with an increased risk of 
bladder cancer (Villanueva et al. 2004). A large 
study on bladder cancer in Spain was the first 
to examine exposure to THMs through inges-
tion of water and through inhalation and der-
mal absorption during showering, bathing, and 
swimming in pools (Villanueva et al. 2007). 
Participants with household THM levels 
> 49 µg/L had twice the risk of bladder cancer 
as those with levels < 8 µg/L. The risks associ-
ated with tasks resulting in high exposure via 
inhalation and dermal absorption were higher 
than those for ingestion. In the same study, an 
increased risk was found for subjects attending 
swimming pools [odds ratio = 1.6; 95% confi-
dence interval (CI), 1.2–2.1]. In another study, 
Nelemans et al. (1994) hypothesized that DBPs 
could be partly responsible for increased risk for 
melanoma among swimmers. 
Several DBPs, including some THMs, 
are genotoxic, and all four regulated THMs 
(chloro form, bromoform, bromo dichloro-
methane, and chloro dibromo methane) are car-
cinogenic in rodents (reviewed by Richardson 
et al. 2007). Chloro form is not mutagenic; 
however, the brominated THMs are, and 
they are activated to mutagens by glutathione 
S‑transferase theta-1 (GSTT1) (DeMarini 
et al. 1997; Pegram et al. 1997). Bromo-
dichloro methane has been shown to induce 
mutagenic activity in human urine (Leavens 
et al. 2007). All regulated THMs other than 
chloro dibromo methane have been shown to 
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Background: Exposure to disinfection by-products (DBPs) in drinking water has been associated with 
cancer risk. A recent study (Villanueva et al. 2007; Am J Epidemiol 165:148–156) found an increased 
bladder cancer risk among subjects attending swimming pools relative to those not attending. 
oBjectives: We evaluated adults who swam in chlorinated pools to determine whether exposure to 
DBPs in pool water is associated with biomarkers of genotoxicity. 
Methods: We collected blood, urine, and exhaled air samples from 49 non smoking adult volun-
teers before and after they swam for 40 min in an indoor chlorinated pool. We estimated associa-
tions between the concentrations of four trihalomethanes (THMs) in exhaled breath and changes 
in micronuclei (MN) and DNA damage (comet assay) in peripheral blood lymphocytes before and 
1 hr after swimming; urine mutagenicity (Ames assay) before and 2 hr after swimming; and MN in 
exfoliated urothelial cells before and 2 weeks after swimming. We also estimated associations and 
interactions with polymorphisms in genes related to DNA repair or to DBP metabolism.
results: After swimming, the total concentration of the four THMs in exhaled breath was seven 
times higher than before swimming. The change in the frequency of micro nucleated lymphocytes 
after swimming increased in association with higher exhaled concentrations of the brominated 
THMs (p = 0.03 for bromo dichloro methane, p = 0.05 for chloro dibromo methane, p = 0.01 for 
bromoform) but not chloro form. Swimming was not associated with DNA damage detectable by 
the comet assay. Urine mutagenicity increased significantly after swimming, in association with the 
higher concentration of exhaled bromoform (p = 0.004). We found no significant associations with 
changes in micronucleated urothelial cells. 
conclusions: Our findings support potential genotoxic effects of exposure to DBPs from swim-
ming pools. The positive health effects gained by swimming could be increased by reducing the 
potential health risks of pool water.
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induce DNA damage in vitro as detected by the 
comet assay, and some studies have found that 
chloro dibromo methane induced chromosomal 
aberrations and sister chromatid exchanges 
and that bromoform induced sister chromatid 
exchanges and micronuclei (MN) [International 
Agency for Research on Cancer (IARC) 1999; 
Richardson et al. 2007]. Extensive quantitative 
testing of the mutagenic and genotoxic potency 
of DBPs has shown that iodinated compounds 
such as dichloro iodo methane are generally 
more toxic than are brominated DBPs, and 
DBPs that are both iodinated and brominated 
are more genotoxic than are chlorinated DBPs 
(Richardson et al. 2007).
Metabolism of DBPs is mediated by 
enzymes from the glutathionine S-transferase 
(GST) and cytochrome P450 (CYP) families. 
Evaluation of polymorphisms in GSTT1, 
a gene involved in the metabolism of bro-
minated THMs, has indicated significantly 
stronger associations between THM exposure 
and bladder cancer among subjects with func-
tioning GSTT1 (+/+ or +/– genotypes) than 
among subjects with deletions in both alleles 
(–/–) (Cantor et al. 2010). This was consistent 
with early studies showing that GSTT1 acti-
vated the brominated THMs, but not chloro-
form, to mutagens in a transgenic strain of 
Salmonella (DeMarini et al. 1997; Pegram 
et al. 1997). GSTZ1 catalyzes the oxygenation 
of dichloro acetic acid to glyoxylic acid and 
plays a critical role in the tyrosine degrada-
tion pathway and in alpha-haloacid metabo-
lism (Board and Anders 2005). CYP2E1, 
CYP1A2, CYP3A4, and CYP2A6 are involved 
in the metabolism of chloro form and bromo-
dichloro methane (Allis and Zhao 2002; 
Gemma et al. 2003; Leavens et al. 2007; Zhao 
and Allis 2002), and CYP2D6 variants have 
been found to modify THM blood levels after 
showering (Backer et al. 2008). Metabolic 
activation of bromo dichloro methane by 
GSTT1 may result in the formation of 8-ox-
oguanidine DNA adducts that are repaired 
by base-excision repair through the expres-
sion of genes such as OGG1 (8-oxo guanine 
DNA glycosylase), APEX1 [APEX nuclease 
(multi functional DNA repair enzyme) 1], 
and XRCC1 (X-ray repair complementing 
defective repair in Chinese hamster cells 1). 
There is some evidence that genetic variants 
of XRCC1 influence MN formation, as might 
variants in the ERCC2 (excision repair cross-
complementing rodent repair deficiency, 
complementation group 2) gene, which is 
part of the nucleotide-excision repair (NER) 
pathway (Iarmarcovai et al. 2008). On the 
other hand, chloro form exposure results in 
increased expression of APEX1 in rat liver 
(Zidek et al. 2007). Polymorphisms in these 
DNA repair genes also have been associated 
with bladder cancer, which has been associ-
ated most consistently with DBP exposure.
Genotoxicity evaluations are used exten-
sively in studies of health effects of environ-
mental exposures. These assays can be carried 
out using easily obtainable human cells, such 
as peripheral blood lymphocytes (PBLs) and 
exfoliated urothelial cells from urine, and 
have been used to evaluate the geno toxicity of 
DBPs (Liviac et al. 2009; Ranmuthugala et al. 
2003; Richardson et al. 2007). Methods used 
to detect primary DNA damage include the 
comet assay, which detects single- and double-
strand breaks, alkali-labile sites, and transient 
DNA repair breaks (Dusinska and Collins 
2008). Primary DNA damage can be repaired 
easily; thus, it is necessary to also use bio-
markers of fixed damage, which are probably 
more relevant for human risk assessment. In 
this context, the MN assay is a well-validated 
methodology that provides a measure of both 
chromosome breakage and chromosome loss, 
and it has been shown to be a relevant bio-
marker for cancer risk (Bonassi et al. 2007).
Urinary mutagenicity has been examined 
in occupational and environmental settings 
for more than three decades as a general cost-
efficient assessment of systemic geno toxicity 
(Cerná and Pastorková 2002). Although sev-
eral experi mental studies have evaluated the 
mutagenicity of DBPs, only Leavens et al. 
(2007) have evaluated the effect of a DBP on 
urinary mutagenicity in humans with con-
trolled dermal and oral exposures; they found 
that urinary mutagenicity levels increased after 
exposure to bromo dichloro methane, particu-
larly among subjects exposed per cutaneously 
compared with orally.
To evaluate the genotoxicity of swimming 
pool water in swimmers, we examined the 
above-mentioned biomarkers of geno toxicity 
in an experimental study in which adults 
swam for 40 min in a chlorinated, indoor 
swimming pool. We compared the biomarker 
results with an internal measure of exposure: 
the concentrations of four THMs in exhaled 
breath as determined in a companion study 
(Font-Ribera et al. 2010). We also evaluated 
the impact of genotype on the biomarker 
responses relative to THM exposure.
Materials and Methods
Study design. Fifty non smoking volun teers 
18–50 years of age were recruited through 
open advertisements on the Internet and at 
local universities, avoiding any direct personal 
contact (e.g., e-mailing) because this is pro-
hibited in research centers in Spain. A screen-
ing questionnaire was used to verify eligibility. 
Compensation was provided to subjects, who 
signed an informed consent form that acknowl-
edged this compensation. We selected a single, 
indoor, 25-m-long chlorinated swimming pool 
in Barcelona, Spain, for the study, which was 
conducted during May, June, September, and 
October 2007. Figure 1 shows the design of 
the swimming pool study.
We asked subjects not to swim for 1 week 
before the swimming experiment. For the 
experiment, subjects were asked to swim for 
40 min in the pool, and the time and distance 
of swimming were recorded for each individ-
ual. We selected 40 min based on our estimate 
of the usual time that non competitive swim-
mers swim. Biological samples (exhaled breath, 
blood, and urine) were collected both before 
and after swimming at specified time periods 
(Font-Ribera et al. 2010), and questionnaires 
were completed before swimming. THMs in 
exhaled breath were measured within a few 
minutes after swimming and before taking a 
shower. Blood samples were collected on aver-
age 1 hr after swimming, and urine samples 
were collected on average 2 hr after swimming. 
A second urine sample was collected 2 weeks 
after swimming; this sample was used for 
analysis of MN in exfoliated urothelial cells. 
One subject failed to adequately complete the 
procedures for the measurement of THMs 
in exhaled breath and was excluded, leaving 
49 subjects for the final analysis. All laboratory 
analyses were blind concerning before or after 
swimming. The study protocol was approved 
by the ethics committee of the research cen-
ter, and, as noted above, all subjects signed 
informed consent forms.
Questionnaire. Subjects completed a self-
administered questionnaire that included 
Figure 1. Design of the swimming pool study. Samples were collected before swimming and minutes 
(exhaled breath), 1 hr (blood for MN and comet), 2 hr (urine for mutagenicity testing), and 2 weeks (urine 
for MN in exfoliated cells) after swimming. 
1 week without swimming
(wash-out)
Swim in chlorinated pool,
40 min
Before swimming
Exhaled air: THMs
Blood: MN, comet
Urine: MN, mutagenicity
After swimming
Exhaled air: THMs, minutes after
Blood: MN, Comet, 1 hr after
Urine: MN, mutagenicity, 2 hr after
Urine: MN,
2 weeks after
Genotoxicity in individuals who swim in chlorinated pools
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information on socio demographics (e.g., age, 
education, occupation, basic residential and 
commuting information), detailed water-re-
lated habits (e.g., fluid ingestion, showers, 
baths, swimming pools), physical activity, 
medical history and drugs, and lifestyle (e.g., 
past smoking, second-hand smoke, use of hair 
dyes), as well as a food-frequency question-
naire validated in the Spanish population 
and a short 24-hr activity and recent-disease 
questionnaire. Measurement of physical activ-
ity during swimming was done indirectly by 
recording each individual’s swimming pattern 
(number of laps).
Exposure assessment. A detailed descrip-
tion of measurements of THMs in air and 
exhaled breath before and after swimming 
is reported by Font-Ribera et al. (2010), 
and information on levels of DBPs in the 
water and water mutagenicity is reported by 
Richardson et al. (2010). THMs in air and 
water were determined at each swimming ses-
sion following a specific protocol. There are 
distinct advantages of using exhaled breath to 
assess THM intake: It is non invasive and pro-
vides a representative estimate of the concen-
tration of contaminants in blood due to the 
gas exchange in the blood/breath interface in 
the lungs. Analysis of air and exhaled breath 
involved solid-phase adsorption on Tenax 
TA (Supelco, Bellefonte, PA, USA). Exhaled 
breath samples were collected using a portable 
system that consisted of a Haldane-Priestley 
tube modified to concentrate aliquots of 
exhaled breath from one or more exhalations. 
Water samples were analyzed with a purge-
and-trap concentrator equipped with a Tenax 
silica gel-charcoal trap (Supelco). 
Comet analysis in PBLs. The comet assay 
was performed as described previously (Singh 
et al. 1988) with minor modifications. Blood 
samples were collected in Vacutainers con-
taining EDTA. Samples were kept chilled, 
and the length of time between blood collec-
tion and sample processing was a few hours 
(Anderson et al. 1997). One hundred cells 
selected randomly (50 cells from each of the 
two replicate slides) were analyzed per sample. 
Olive tail moment (OTM) and percentage of 
DNA in the tail, used as meas ures of DNA 
damage, were computed using Komet soft-
ware, version 5.5 (Kinetic Imaging, Liverpool, 
UK); [see also Supplemental Material 
(doi:10.1289/ehp.1001959)].
MN analysis in PBLs. Blood was obtained 
from each subject by venipuncture using hep-
arinized Vacutainers and sent immediately to 
the laboratory for the lymphocyte cultures. 
To determine the frequency of binucleated 
cells with MN and the total number of MN, 
a total of 1,000 binucleated cells with well-
preserved cytoplasm (500/replicate) were 
scored for each subject. In addition, we scored 
500 lympho cytes to evaluate the percentage of 
cells with one to four nuclei and calculated the 
cyto kinesis block proliferation index (Surrallés 
et al. 1995). Microscopic scoring was per-
formed on coded slides [see also Supplemental 
Material (doi:10.1289/ehp.1001959)].
MN analysis in urothelial cells. Urine 
samples (~ 50 mL) were collected into plas-
tic vials before swimming and again 2 weeks 
later; samples were then sent to the labora-
tory and processed the same day. We selected 
2 weeks because this is the amount of time 
required for exfoliation of cells from the 
urothelium (Espinoza et al. 2008). We fol-
lowed the criteria for MN evaluation sug-
gested by Stick et al. (1983) as updated by 
subsequent guidelines by Fenech et al. (2003). 
The frequency of urothelial cells with MN 
and the total number of MN were determined 
for each analyzed subject. We scored only 
cells with a typical morphology correspond-
ing to urothelial cells in order to avoid any 
kind of bias, especially in women where many 
squamous cells not of urothelial origin are 
observed. Although bacteria were present in a 
few urine samples, they did not interfere with 
the scoring [see also Supplemental Material 
(doi:10.1289/ehp.1001959)].
Urine mutagenicity. Urine samples 
(30 mL) collected before and 90–120 min 
after exposure were evaluated for mutagenic-
ity in the Salmonella (Ames) muta genicity 
plate-incorporation assay (Maron and 
Ames 1983) in strain YG1024 with S9 mix. 
YG1024 is a frameshift strain derived from 
TA98 (hisD3052, ΔuvrB, rfa, pKM101) that 
contains acetyl transferase activity (Watanabe 
et al. 1990), and it has been used extensively 
for urinary mutagenicity studies (Cerná 
and Pastorková 2002). We used only one 
strain because of the limited availability of 
sample. The mutagenic potencies of samples, 
expressed as revertants per milliliter-equivalent 
(rev/mL-eq), were calculated from the slope 
of the regression over the linear portion of 
the dose–response curves. Slopes were calcu-
lated for 43 subjects with samples from before 
and after swimming that were sufficient for 
analyses of mutagenicity at three or more dif-
ferent concentrations [see also Supplemental 
Material (doi:10.1289/ehp.1001959)].
Gene selection and genotyping. We exam-
ined genetic variants, including single-nucleotide 
polymorphisms (SNPs) and copy-number 
variants (CNVs), in three genes involved in 
the metabolism of DBPs (GSTT1, CYP2E1, 
and GSTZ1), four additional genes that may 
play a minor role in the metabolism of DBPs 
(GSTT2B, GSTM1, CYP1A2, and CYP2D6), 
and four DNA repair genes that could be rele-
vant when examining results, particularly for 
the comet assay (APEX1, ERCC2, OGG1, 
XRCC1). We selected tag SNPs combined with 
the functional variants most likely to influence 
gene expression or function. In total, 3 CNVs 
and 17 SNPs were genotyped. For a complete 
list, see Supplemental Material, Tables 1–4 
(doi:10.1289/ehp.1001959).
We performed SNP genotyping using 
the Sequenom platform (Sequenom, Inc., 
San Diego, CA). Two individuals with low 
geno typing frequency (< 75%) and two non- 
Caucasians were excluded from the genetic 
analy es. Genotyping failed completely for the 
following SNPs: rs11101815 and rs915908 
in CYP2E1, rs1799793 in ERCC2, and 
rs28903081 in the XRCC3 gene. The remain-
ing 13 SNPs had a call frequency > 90% [see 
also Supplemental Material (doi:10. 1289/ ehp. 
1001959)].
Statistical analysis. Paired t-tests were used 
to examine changes in the level of biomark-
ers before and after swimming. Associations 
between exposure to THMs measured in 
exhaled breath after swimming and changes in 
markers of genotoxicity before and after swim-
ming were evaluated using linear regression. 
All analyses were adjusted for age and sex. We 
evaluated several other variables as potential 
confounders, including water consumption, 
source of water, anti oxidant intake from diet, 
number of laps swum during the experiment 
(an indication of physical activity), and leisure-
time physical activity. However, because esti-
mated effects were modified only marginally by 
the inclusion of these variables in the models, 
we report results adjusted for age and sex only. 
To estimate the amount of variance in an end 
point due to the concentration of THMs in 
exhaled breath, we used unadjusted models to 
calculate the r2 values. The default p-value used 
to determine statistical significance was < 0.05.
We also tested for genotype devia-
tions from Hardy-Weinberg equilibrium 
(Wigginton et al. 2005). Analysis of single-
marker effect was performed assuming both a 
dominant and an additive (data not shown) 
genetic model, considering the most frequent 
allele as a reference category, and using logistic 
regression implemented in SNPassoc (version 
1.5-1) from R statistical software, version 2.6.1 
(R Development Core Team 2007). To evalu-
ate interactions between changes in THMs 
and gene variants, we included an interaction 
term for dichotomous genotype and THMs in 
the linear regression models.
Results
Among the 50 subjects who participated in 
at least part of the study, 66% were women, 
96% were Caucasian, most were highly 
educated, and by selection criteria, all were 
non smokers, with approximately one-third 
being ex-smokers (Table 1). Sixty-eight per-
cent of subjects were exposed regularly to 
second-hand smoke. About half played regu-
lar sports (once per week), and 11 (22%) 
swam at least once per month. The free chlo-
rine level in the pool water (mean ± SD) was 
Kogevinas et al.
1534 volume 118 | number 11 | November 2010 • Environmental Health Perspectives
1.17 ± 0.4 mg/L and the total THM level was 
45.4 ± 7.3 µg/L. In pool air, the total THM 
level was 74.1 ± 23.7 µg/m3. We excluded one 
subject who failed to adequately complete the 
pro cedures for the measure ment of THMs in 
exhaled breath, leaving 49 subjects for the final 
analysis. In exhaled breath, the THM levels 
after swimming were, on average, about 
7 times those for before swimming. The aver-
age total THM levels before and after swim-
ming were 1.2 and 7.9 µg/m3, respectively, 
and the corresponding average levels for the 
individual THMs were 0.7 and 4.5 µg/m3 for 
chloro form, 0.26 and 1.78 µg/m3 for bromo-
dichloro methane, 0.13 and 1.2 µg/m3 for 
chloro dibromo methane, and 0.1 and 0.5 µg/m3 
for bromoform (tribromo methane).
The average number of MN-positive cells 
per 1,000 binucleated lymphocytes increased 
non significantly from 3.4 before swimming 
to 4.0 after swimming (Table 2). Likewise, 
the average frequency of MN in urothelial 
cells and the level of urinary mutagenicity also 
increased non significantly after swimming 
relative to before swimming. In contrast, we 
observed a small but statistically significant 
decrease in the average amount of DNA dam-
age in PBLs meas ured through the comet assay 
after swimming relative to before swimming 
(Table 2).
In the multivariate analysis, the change 
in the frequency of MN in PBLs before and 
after swimming was associated with the com-
bined concentration of all four THMs meas-
ured in exhaled breath. Specifically, a 1-µg/m3 
increase in total THMs in exhaled breath after 
swimming was associated with an average 
increase of 0.296 MN/1,000 cells; however, 
this increase was not significant (p = 0.09) 
(Table 3). We observed the largest increases 
in MN for the brominated THMs (Table 3), 
with statistically significant increases associated 
with exposure to bromo dichloro methane (1.9 
MN/1,000 cells; 95% CI, 0.21–3.63) and 
bromoform (5.04 MN/1,000 cells; 95% CI, 
1.23–8.84). Based on the r2, the fraction of 
the variance in changes in MN frequency that 
was explained by exposure to bromo dichloro-
methane was 10%; for bromoform this was 
13%. Adjustment for potential confounders, 
including the number of laps swum during 
the experiment (as a measure of physical activ-
ity), resulted in only minor changes in effect 
estimates compared with those adjusted for 
age and sex only [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1001959)].
Total or individual THM concentrations 
in exhaled breath were not associated with the 
level of DNA damage in PBLs as assessed by 
the comet assay, regardless of whether damage 
was quantified based on the OTM (Table 3) 
or the percentage of DNA in the tail (data 
not shown).
MN frequency in exfoliated uro thelial 
cells was increased with a 1-µg/m3 increase 
in chloro dibromo methane (2.4 MN/2,000 
cells; 95% CI, –3.3 to 8.2) and bromoform 
(4.3 MN/2,000 cells; 95% CI, –6.9 to 15.5), 
but estimates were not statistically signifi cant 
(Table 3).
We observed an increase in urinary 
mutagenicity, measured as an increase in the 
slope of the dose–response curve (mutagenic 
potency) before and approximately 1.5 hr after 
swimming, for the combined concentration 
of the four THMs in exhaled breath as well as 
for the concentration of each individual THM 
(Table 3). However, these increases were sta-
tistically significant only for bromoform (5.27; 
95% CI, 1.80–8.75; p = 0.004). Based on the 
r2, the fraction of the variance in change in 
urinary mutagenicity that was explained by 
exposure to bromoform was 16%.
We modeled interactions between dichoto-
mous genotypes and changes in THMs after 
swimming to evaluate modification of esti-
mated effects of THMs on measured outcomes 
by genetic varia tion of genes involved in the 
Table 1. Characteristics of the study population.
Characteristic Number (%)
Sex
Male 17 (34)
Female 33 (66)
Age (years)
Mean ± SD 30.1 ± 6.1
Range 20–51
Ethnicity
Caucasian 48 (96)
Other 2 (4)
Educationa
Secondary 4 (8)
University 45 (92)
Tobacco
Never smokers 36 (72)
Ex-smokers 14 (28)
Second-hand smoke
Yes 34 (68)
No 16 (32)
Regular swimming (≥ once/month)
Yes 11 (22)
No 39 (78)
Regular sport (≥ once/week)
Yes 27 (54)
No 23 (46)
aMissing value for one subject.
Table 2. Change in mean values of biomarkers before and after swimming. 
n Mean ± SD
Biomarker Before After Before After p-Valuea
MN-PBL 49 49 3.4 ± 2.4 4.0 ± 2.8 0.235
OTM-comet-PBL 49 49 1.5 ± 0.7 1.3 ± 0.6 0.008
MN-urothelial 33 33 9.0 ± 9.3 10.3 ± 7.4 0.350
Urine mutagenicity (rev/mL-eq) 43 43 0.6 ± 2.3 1.2 ± 2.2 0.257
Abbreviations: MN-PBL, MNs/1,000 binucleated cells; MN-urothelial, MNs per 2,000 cells; OTM-comet-PBL, OTM/100 cells. 
aPaired t-test.
Table 3. Changes in MN frequency and OTM in PBLs, MN frequency in exfoliated urothelial cells, and 
urine mutagenicity with a 1-µg/m3 increase in total or individual THMs in exhaled breath.
Biomarker, exposure β (95% CI) p-Value
MN-PBL
Total THMs 0.30 (–0.05 to 0.64) 0.09
CHCl3 0.29 (–0.27 to 0.85) 0.31
CHCl2Br 1.92 (0.21 to 3.63) 0.03
CHClBr2 1.71 (–0.02 to 3.44) 0.05
CHBr3 5.04 (1.23 to 8.84) 0.01
OTM-comet-PBL
Total THMs –0.02 (–0.07 to 0.04) 0.53
CHCl3 –0.02 (–0.10 to 0.06) 0.64
CHCl2Br –0.04 (–0.30 to 0.23) 0.79
CHClBr2 –0.14 (–0.40 to 0.13) 0.30
CHBr3 –0.23 (–0.83 to 0.37) 0.45
MN-urothelial cells
Total THMs –0.10 (–1.19 to 1.01) 0.86
CHCl3 –0.47 (–2.11 to 1.18) 0.57
CHCl2Br –0.46 (–6.50 to 5.58) 0.88
CHClBr2 2.44 (–3.32 to 8.20) 0.40
CHBr3 4.29 (–6.87 to 15.45) 0.44
Urine mutagenicity (rev/mL-eq)
Total THMs 0.24 (–0.11 to 0.58) 0.17
CHCl3 0.33 (–0.22 to 0.89) 0.23
CHCl2Br 0.61 (–1.12 to 2.35) 0.48
CHClBr2 0.92 (–0.75 to 2.59) 0.27
CHBr3 5.27 (1.80 to 8.75) 0.004
Abbreviations: CHBr3, bromoform; CHCl2Br, bromo dichloro methane; CHCl3, chloro form; CHClBr2, chloro dibromo methane; 
MN-PBL, MNs/1,000 binucleated cells; MN-urothelial, MNs/ 2,000 cells; OTM-comet-PBL, OTM/100 cells. 
aβ-Coefficients represent a change in the biomarker level for a 1-µg/m3 change in THMs in exhaled air measured after 
swimming. 
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metabolism of DBPs or in DNA repair. Table 4 
shows results of models to assess interactions 
between bromo form (the THM showing the 
most significant associations with the effect 
biomarkers) and polymorphisms in GSTT1, 
GSTZ1, and CYP2E1 metabolism genes. 
Complete results for all gene variants exam-
ined are reported in Supplemental Material, 
Tables 1–4 (doi:10.1289/ehp.1001959).
Subjects with the null GSTT1 genotype 
(–/–; a deletion in both copies of the gene) 
had lower frequencies of MN in urothelial 
cells and lower urinary mutagenicity than did 
those with one (+/–) or none (+/+) of the 
copies deleted, but differences were not sta-
tistically significant (Table 4). We did not 
observe a statistically significant modi fi cation 
by GSTT1 of effects of THMs on MN in 
PBLs, although –/– individuals tended to have 
higher MN levels in lymphocytes than did –/+ 
and +/+ individuals. Statistically significant 
inter actions were found between exposure 
to bromoform and GSTZ1 (rs3177427) for 
MN in PBLs [β coefficient, 10.2 (95% CI, 
3.0–17.3) and 1.4 (95% CI, –3.7 to 6.5) for 
GG vs. AG or AA geno types, respectively] 
and between bromoform and CYP2E1 
(rs915906) for MN in urine [11.6 (95% CI, 
2.5–20.8) and –23.2 (95% CI, –52.4 to 6.1) 
for TT vs. CT or CC genotypes, respectively; 
Table 4]. We also found statistically signifi-
cant inter actions between bromoform expo-
sure and gene variants on MN in PBLs for 
GSTT2B [9.6 (95% CI, –0.11 to 19.3) and 
1.95 (95% CI, –2.32 to 5.51) for +/+ vs. –/+ 
or –/– genotypes, respectively] and APEX1 
[9.5 (95% CI, 3.3–15.6) and –2.5 (95% CI, 
–9.4 to 4.5) for TT vs. GT or GG genotypes, 
respectively; see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1001959)] and 
between bromoform and GSTM1 on MN 
in urine [–23.1 (95% CI, –50.5 to 4.5) and 
8.1 (95% CI, –2.1 to 18.3) for –/– vs. –/+ or 
+/+ genotypes, respectively; see Supplemental 
Material, Table 2]. No statistically signifi-
cant inter actions were found between bromo-
form and any of the gene variants associated 
with DNA damage that we assessed using the 
comet assay (Table 4; see also Supplemental 
Material, Table 4). 
Discussion
This is the first study of DBP geno toxicity 
among people who swam in a chlorinated 
pool. Biomarkers of genotoxic effects have 
been used extensively to evaluate potential 
health effects of environ mental exposures, and 
the MN assay has been shown to be a predic-
tive biomarker of cancer risk within a popula-
tion of healthy subjects (Bonassi et al. 2007). 
In the present study, we observed increases 
in two bio markers of geno toxicity (MN in 
PBLs and urinary muta genicity) based on the 
change in brominated THM concentration in 
exhaled breath after swimming; however, there 
was no association with exposure to chloro-
form, which is not genotoxic (Richardson 
et al. 2007). We found no association between 
exposure to THMs in the pool and DNA 
damage in PBLs as meas ured by the comet 
assay. Associations were not dependent on 
confounding factors. We found some indica-
tion that responses to THMs were modified 
by variation in genes that metabolize these 
compounds, but there was limited power to 
evaluate gene–environment inter actions.
The four THMs we evaluated are the 
most common DBPs in swimming pool water 
(Richardson et al. 2010). Although THMs 
are not considered to be the most toxic of the 
DBPs, all four are carcinogenic in rodents 
(Richardson et al. 2007). The brominated 
THMs have been shown to be mutagenic 
after activation by GSTT1, and some of 
them have been shown to induce chromo-
somal aberrations, sister chromatid exchanges, 
and/or MN in animal and human cells (IARC 
1999; Richardson et al. 2007). In contrast, 
chloro form is not geno toxic (Richardson et al. 
2007), and unlike the brominated THMs, 
it is not activated by GSTT1 (Pegram et al. 
1997). Thus, our finding of an association 
between exposure to brominated THMs and 
an increased response among various genotox-
icity biomarkers—but the absence of such an 
association with chloro form exposure—is con-
sistent with the toxicology of these THMs.
Our results are also consistent with exten-
sive quantitative genotoxicity data on DBPs 
showing that brominated DBPs are generally 
more geno toxic and carcinogenic than chlo-
rinated DBPs (Plewa et al. 2008; Richardson 
et al. 2007). In our study, we evaluated only 
THMs that are known to be the most common 
DBPs in swimming pool water and that exhibit 
high uptake by swimmers (Zwiener et al. 
2007). Levels of halo acetic acids can also be 
high in swimming pools; however, the uptake 
of these DBPs may be low because the halo-
acetic acids are not volatile and are not adsorbed 
efficiently by the skin (Xu et al. 2002). Among 
the chemical classes of DBPs, the rank order 
of the combined cytotoxicity and genotoxicity 
in Chinese hamster ovary cells was halo nitro-
methanes > halo acetamides > halo aceto nitriles 
> halo acetic acids > halo methanes (Richardson 
et al. 2007). Future studies of swimmers should 
evaluate more completely the uptake and 
potential effects of a range of DBPs and other 
compounds present in pool water.
We found tthat evaluation of modification 
of environmental exposure by genetic polymor-
phisms was of low statistical power given the 
relatively small sample size; thus, these findings 
should be interpreted with caution. The main 
hypotheses focused on a potential modification 
Table 4. Interaction between polymorphisms in three genes involved in DBP metabolism and the effects of exposure to bromoform on MN and the comet assay 
in PBLs, MN in exfoliated urothelial cells, and urinary mutagenicity. 
MN in PBLs MN in exfoliated urothelial cells Urinary mutagenicity Comet assay
Gene Genotype n β (95% CI) n β (95% CI) n β (95% CI) n β (95% CI)
GSTT1 –/– 16 7.8 (1.9 to 13.7) 10 –5.2 (–48.6 to 38.3) 14 1.9 (–4.2 to 8.0) 16 –0.04 (–0.8 to 0.7)
–/+, +/+ 30 3.4 (–1.6 to 8.3) 23 1.7 (–11.1 to 14.6) 26 7.6 (3.0 to 12.2) 30 –0.4 (–1.3 to 0.4)
CYP2E1
rs2070673 TT 27 4.4 (–0.4 to 9.1) 21 10.6 (0.9 to 20.2) 22 6.9 (0.7 to 13.0) 27 –0.3 (–1.1 to 0.5)
AT, AA 16 –0.03 (–7.5 to 7.5) 10 –11.5 (–41.1 to 18.1) 15 3.0 (–2.9 to 9.0) 16 0.05 (–1.3 to 1.4)
rs915906 TT 28 6.7 (2.2 to 11.1) 22 11.6 (2.5 to 20.8)* 22 5.8 (1.8 to 9.9) 28 –0.4 (–1.03 to 0.2)
CT, CC 14 –5.9 (–14.1 to 2.3) 9 –23.2 (–52.4 to 6.1)* 14 3.1 (–4.0 to 10.2) 14 –0.1 (–2.2 to 2.0)
rs915907 CC 30 3.7 (–1.8 to 9.1) 22 12.1 (–1.3 to 25.5) 27 4.9 (–0.9 to 10.6) 30 0.4 (–0.5 to 1.3)
CA, AA 14 6.6 (–2.0 to 15.1) 9 9.8 (–12.3 to 31.9) 11 5.4 (–5.1 to 15.8) 14 0.9 (–1.7 to –0.04)
rs2515641 CC 35 5.8 (1.7 to 9.9) 25 7.6 (–3.2 to 18.4) 29 5.5 (1.1 to 10.0) 35 –0.3 (–0.9 to 0.3)
CT 9 –0.4 (–14.1 to 13.3) 6 –11.0 (–23.6 to 1.6) 9 2.9 (–9.7 to 15.5) 9 0.8 (–2.0 to 3.5)
rs2249695 CC 25 4.2 (–0.8 to 9.2) 21 10.6 (0.9 to 20.2) 21 7.3 (2.8 to 11.9) 25 –0.3 (–1.1 to 0.5)
CT, TT 19 7.5 (1.1 to 13.8) 10 –11.5 (–41.1 to 18.1) 17 2.5 (–2.7 to 7.6) 19 –0.1 (–1.1 to 0.8)
GSTZ1
rs3177427 GG 22 10.2 (3.0 to 17.3)* 19 –0.2 (–19.4 to 19.0) 21 3.5 (–1.8 to 8.7) 22 –0.2 (–1.2 to 0.7)
AG, AA 22 1.4 (–3.7 to 6.5)* 12 8.7 (–5.6 to 22.9) 17 8.7 (2.0 to 15.4) 22 –0.5 (–1.5 to 0.5)
rs1046428 CC 29 3.3 (–1.0 to 7.5) 20 5.8 (–5.7 to 17.2) 24 6.5 (1.9 to 11.2) 29 –0.3 (–1.1 to 0.4)
CT, TT 14 –5.4 (–18.5 to 7.8) 11 21.1 (–7.6 to 49.8) 13 –2.1 (–18.9 to 14.7) 14 0.6 (–1.9 to 3.2)
*p < 0.05. 
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of the effect by variants in a few genes (GSTT1, 
GSTZ1, and CYP2E1) that code enzymes 
that are important for DBP metabolism 
(Richardson et al. 2007). Similar to what has 
been shown for muta genesis in bacteria and 
DNA adducts in rodents (DeMarini et al. 
1997; Pegram et al. 1997; Ross and Pegram 
2003), individuals with the GSTT1 null geno-
type had lower frequencies of MN in uro thelial 
cells and lower urinary muta genicity than those 
with at least one functional allele; however, 
in our study, the differences were not statisti-
cally significant. We did not observe modifica-
tion by GSTT1 of effects of THMs on MN in 
PBLs, consistent with a lack of GSTT1 expres-
sion in lymph ocytes (Wang et al. 2000). In 
contrast, individuals bearing GSTT2B +/+ had 
higher numbers of MN in PBLs than did other 
subjects. The CNV encompassing GSTT2B, 
which modifies GSTT2 gene expression, is in 
linkage dis equilibrium with the GSTT1 CNV 
(Zhao et al. 2009). All three of these genes 
are located in the same cluster, and combined 
effects cannot be excluded; however, the role of 
GSTT2 and GSTT2B genes on DBP detoxifi-
cation is unknown. Limited experimental data 
are available for GSTZ1 and CYP2E1 in rela-
tion to DBP exposure. In the present study, 
we identified differences between subjects of 
different geno types, with those associated with 
CYP2E1 being statistically significant. These 
findings should be verified in further studies.
Potential confounding was minimized in 
our study, which involved comparing individu-
als with themselves before and after an exposure 
over a limited time period. Any changes in bio-
markers were likely attributed to one of three 
factors: exposures related to swimming pools, 
swimming itself, or chance. As expected, con-
trol of other lifestyle factors and environmental 
exposures did not modify results. Some studies 
(Schiffl et al. 1997) have shown physical activ-
ity to be associated with geno toxicity through 
an effect on oxidative stress, but the results are 
not consistent (Battershill et al. 2008; Stefanie 
et al. 2008). In our study population, adjust-
ment for the intensity of physical activity dur-
ing swimming indicated no confounding of 
effect estimates for exposure to DBPs. 
Confounding could be more of a problem 
for the analysis of MN in exfoliated urothelial 
cells, which were collected 2 weeks after swim-
ming. Although we did control for several life-
style factors in the analysis, it is still possible 
that results in urine could have been affected 
more by uncontrolled confounding. Chance 
could be an explanation for some of the results 
and is particularly a problem for the evaluation 
of gene–environment inter actions. In the main 
analyses of exposure and effect biomarkers, 
however, we made only a few comparisons, 
and the issue of chance findings due to mul-
tiple comparisons was minor. In addition, the 
identification of more pronounced genotoxic 
effects for the potentially more toxic bromi-
nated compounds compared with chloro form 
argues against an effect of chance.
The timing of the collection of biological 
samples is crucial when evaluating biomarkers 
of effect. Because of constraints in the study 
protocol, the first samples were collected dur-
ing the 2-hr period after swimming—and 
2 weeks after swimming for evaluation of 
exfoliated urothelial cells. Because of the lack 
of previous studies of this type with swim-
mers, we had no precedence to follow, and 
the timing of blood collection that we used 
might not have been the most appropriate for 
some of the assays. Specifically, it is possible 
that collecting blood approximately 1 hr after 
swimming for chemicals that are metabolized 
rapidly and that are of relatively low toxicity 
might not necessarily be appropriate for the 
comet assay because DNA damage induced 
by DBPs may already have been repaired 
before the sample is collected (Komaki et al. 
2009; Liviac et al. 2009). However, studies 
in rodents frequently assess DNA damage in 
lymphocytes 3–4 hr after exposure. We col-
lected urine 2 hr after swimming for mutagen-
icity analysis and also 2 weeks after swimming 
for MN analysis. This 2-week time period was 
selected to allow time for the exfoliation of 
cells from the uro thelium exposed at the time 
of the experiment (Espinoza et al. 2008).
Swimming has significant positive health 
effects related to the benefits of exercise and 
has some advantages over land-based activi-
ties for people of all ages and physical abilities 
(Zwiener et al. 2007). To retain the positive 
aspects of aquatic activities, regulators and 
researchers have turned their attention to the 
hygienic aspects of the quality of pool water, 
as well as of its chemical composition. It will 
be important to maintain microbial disinfec-
tion while minimizing potentially harmful 
DBPs. The goal is to maintain the positive 
health effects of swimming while reducing 
other potential adverse health risks.
Conclusion
We found that exposure to brominated THMs 
through swimming in chlorinated pools was 
associated with increases in genotoxicity bio-
markers. When we used different geno toxicity 
and mutagenicity assays, our findings were con-
sistent. We found that only brominated THMs 
were associated with higher genotoxicity; 
chloro form was not. Our results are also consis-
tent with the presence of mutagenic and geno-
toxic DBPs in pool water and the mutagenic 
activity of the pool water (~ 1,200 rev/L-eq in 
Salmonella strain TA100), of which, as noted 
by Richardson et al. (2010), were present at 
levels similar to those found in drinking water. 
However, Richardson et al. (2010) found that 
the concentrations of nitrogen- containing DBPs 
were higher in pool water than in drinking 
water. Although our study had low power to 
estimate unambiguously the effects of genetic 
variation on responses to chemical exposures 
during swimming, it appears plausible that such 
variation exists. Our findings, which should be 
verified in larger studies, indicate that the posi-
tive health effects gained by swimming could be 
increased by reducing the potential heath risks 
of pool water.
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